The emotional and psychological impact of multiple sclerosis relapses
- PMID: 17350045
- DOI: 10.1016/j.jns.2007.01.061
The emotional and psychological impact of multiple sclerosis relapses
Abstract
Acute relapses of multiple sclerosis (MS) are experienced as crises that disrupt the status quo for individuals with MS and their families. These unpredictable--and always unexpected--events elicit strong reactions, including grief, anxiety, anger, and guilt, as people struggle to understand why they occur. Although early relapses are a signal for most MS specialists to recommend treatment with one of the approved disease-modifying therapies, the remissions that follow contribute to patient and family denial about the realities of the disease, making it difficult for patients to begin and to adhere to ongoing treatment. Each ensuing attack confronts this denial, forcing patients and families to acknowledge the MS diagnosis and begin adapting to the demands of the illness in their daily lives. This paper discusses the meaning attributed by individuals and families to relapses leading to the MS diagnosis and the recommendation for disease-modifying therapy, the adjustments that are made by patients and their families to residual deficits following acute episodes, and suggestions for clinicians on how they might facilitate the adjustment process.
Similar articles
-
The psychosocial effect of multiple sclerosis: the impact of relapses.J Neurol Sci. 2007 May 15;256 Suppl 1:S34-8. doi: 10.1016/j.jns.2007.01.059. Epub 2007 Mar 9. J Neurol Sci. 2007. PMID: 17350047 Review.
-
Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study.Mult Scler. 2008 Nov;14(9):1262-8. doi: 10.1177/1352458508095331. Epub 2008 Aug 28. Mult Scler. 2008. PMID: 18755825
-
Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study.Mult Scler. 2008 Jun;14(5):640-55. doi: 10.1177/1352458507086463. Mult Scler. 2008. PMID: 18566028
-
Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.Psychol Psychother. 2009 Mar;82(Pt 1):41-56. doi: 10.1348/147608308X345614. Epub 2008 Aug 25. Psychol Psychother. 2009. PMID: 18727845
-
Relapses matter: the costs & consequences of multiple sclerosis relapses.J Neurol Sci. 2007 May 15;256 Suppl 1:S1-4. doi: 10.1016/j.jns.2007.01.058. Epub 2007 Mar 9. J Neurol Sci. 2007. PMID: 17350044 Review. No abstract available.
Cited by
-
Examining the Relationship Between Family Caregivers' Emotional States and Ability to Empathize with Patients with Multiple Sclerosis: A Pilot Study.Int J MS Care. 2016 May-Jun;18(3):122-8. doi: 10.7224/1537-2073.2015-023. Int J MS Care. 2016. PMID: 27252599 Free PMC article.
-
Validation of a new quality of life scale related to multiple sclerosis and relapses.Qual Life Res. 2013 Oct;22(8):1943-54. doi: 10.1007/s11136-012-0334-0. Epub 2012 Dec 18. Qual Life Res. 2013. PMID: 23247892
-
The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta-analysis.Br J Clin Pharmacol. 2020 Apr;86(4):637-645. doi: 10.1111/bcp.14198. Epub 2020 Feb 8. Br J Clin Pharmacol. 2020. PMID: 31869429 Free PMC article. Review.
-
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.J Neurol. 2014 Sep;261(9):1781-8. doi: 10.1007/s00415-014-7395-7. Epub 2014 Jun 28. J Neurol. 2014. PMID: 24972678 Free PMC article. Clinical Trial.
-
Anxiety Sensitivity and Its Relation to Anxiety in Multiple Sclerosis.Psychiatry Clin Psychopharmacol. 2021 Dec 1;31(4):434-441. doi: 10.5152/pcp.2021.21039. eCollection 2021 Dec. Psychiatry Clin Psychopharmacol. 2021. PMID: 38765653 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources